<DOC>
	<DOCNO>NCT02754687</DOCNO>
	<brief_summary>The long term objective develop new male hormone 11-β Methyl Nortestosterone Dodecylcarbonate ( 11β-MNTDC ) male hormonal contraceptive .</brief_summary>
	<brief_title>Single Dose , Dose-Ranging Study 11-β Methyl Nortestosterone Dodecylcarbonate ( 11β-MNTDC ) Healthy Men</brief_title>
	<detailed_description>This Phase I multicenter , double-blind , single dose , dose-ranging study , healthy men follow inpatient basis evaluate safety tolerability , pharmacokinetics pharmacodynamics 11β-methyl nortestosterone dodecylcarbonate ( 11β-MNTDC ) . This single dose , dose-ranging study 4 escalating dos conduct two center . Initially , 12 men enrol total , 6 men center , goal minimum 12 healthy male subject complete study ( 10 active drug 2 placebo ) feed fast state dose . Each 4 dos 11β-MNTDC administer first fasting fed . Each dose 11β-MNTDC administered 28 day apart +/- 14 day time interval fast feed dose approximately 7 day ( -2/+9 day ) 7 14 day washout occur dose escalation .</detailed_description>
	<mesh_term>Nandrolone</mesh_term>
	<mesh_term>Nandrolone decanoate</mesh_term>
	<mesh_term>Nandrolone phenpropionate</mesh_term>
	<criteria>1 . Male volunteer good health confirm physical examination , medical history , clinical laboratory test blood urine time screen . 2 . 18 50 year age ( inclusive ) . 3 . BMI ≤ 33 calculated weight kg/ ( height m2 ) . 4 . No history hormonal therapy use last three month prior first screen visit . 5 . Subject agree use recognize effective method contraception female partner ( i.e . minimum , use barrier plus additional method contraception ) course study treatment recovery phase . 6 . Subjects refrain donate blood plasma study period . 7 . Subjects advise refrain/abstain alcoholic beverage grapefruit juice study period . 8 . Subjects use cannabis recreational drug least 2 week complete screen study . 9 . In opinion investigator , subject able comply protocol , understand sign inform consent HIPAA form . 10 . Does meet exclusion criterion . 1 . Men participate another clinical trial involve investigational drug within last 30 day prior first screen visit . 2 . Men live catchment area clinic within reasonable distance study site . 3 . Clinically significant abnormal physical laboratory finding screen . 4 . Elevated PSA ( level ≥ 2.5 ng/mL ) , accord local laboratory normal value . 5 . Abnormal serum chemistry value , accord local laboratory reference range indicate liver kidney dysfunction may consider clinically significant except : upper limit fast bilirubin le 2 mg/dL , upper limit cholesterol le 221 mg/dL , upper limit fast triglyceride le 201 mg/dL . 6 . Use androgens within 2 month first screen visit . 7 . Ongoing use body build nutritional supplement . 8 . Systolic BP &gt; 135 mm Hg Diastolic blood pressure BP &gt; 85 mm Hg ; ( ( BP ) Blood pressure take 3 time 5 minute interval mean measurement consider ) . 9 . Clinically significant abnormal EKG QTc interval &gt; 450 msec . 10 . History hypertension , include hypertension control treatment . 11 . Benign malignant liver tumor ; active liver disease . 12 . History breast carcinoma . 13 . Known history androgen deficiency due hypothalamicpituitary testicular disease . 14 . Known history cardiovascular , renal , hepatic prostatic disease significant psychiatric illness . 15 . Positive serology active Hepatitis ( immunizationrelated serology ) HIV screen visit . 16 . A serious systemic disease diabetes mellitus obesity ( body weight great BMI &gt; 33 kg/m2 ) . 17 . History know , untreated sleep apnea . 18 . Known suspected alcoholism drug abuse may affect metabolism/transformation steroid hormone study treatment compliance . 19 . Partner known pregnant . 20 . Men desire fertility within first 24 week study participation . 21 . Men participate competitive sport drug screening prohibit substance ( include anabolic steroid ) routine advise relative temporary hazard participate study may sport status .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>male contraception</keyword>
	<keyword>healthy men</keyword>
	<keyword>androgen</keyword>
	<keyword>Nortestosterone</keyword>
	<keyword>Dodecylcarbonate</keyword>
	<keyword>11-Beta</keyword>
	<keyword>11β</keyword>
	<keyword>contraception</keyword>
</DOC>